Patent Assignment
Reel/Frame 035050/0813
Change of Name
Recorded: 2015-02-19
Pages: 4
Assignor
AMYLIN PHARMACEUTICALS, INC.
Executed: 2012-08-08
Assignee
AMYLIN PHARMACEUTICALS, LLC
9360 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Engineered Poypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
Application:
14/129,793 →
Publication:
US 2014/0256621
Related Assignments
(11)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 19, 2015
From: ERICKSON, MARY; LITZINGER, DAVID C.; GHOSH, SOUMITRA S.; GUO, ZIJIAN
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 034987/0601 →
Assignment of Assignor's Interest
Feb 19, 2015
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 034987/0686 →
Assignment of Assignor's Interest
Feb 19, 2015
From: AMYLIN PHARMACEUTICALS, LLC; ASTRAZENECA PHARMACEUTICALS LP
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 034987/0659 →
Assignment of Assignor's Interest
Feb 19, 2015
From: EKBLAD, CAROLINE
To: AMYLIN PHARMACEUTICALS, INC.; AFFIBODY AB
Reel/Frame 034987/0612 →
Patent Security Agreement
Jun 15, 2016
From: AEGERION PHARMACEUTICALS, INC.
To: QLT INC.
Reel/Frame 039024/0965 →
Security Agreement
Jun 16, 2016
From: AEGERION PHARMACEUTICALS, INC.
To: SILICON VALLEY BANK
Reel/Frame 039050/0882 →
Release of Security Interest
Nov 30, 2016
From: SILICON VALLEY BANK
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 040748/0974 →
Change of Name
Mar 16, 2018
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 045619/0257 →
Patent Security Agreement
Apr 6, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 045853/0148 →
Release of Security Interest
Sep 24, 2019
From: NOVELION THERAPEUTICS INC. (F/K/A QLT, INC.)
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0738 →
Release of Security Interest
Sep 24, 2019
From: NOVELION THERAPEUTICS INC.
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0844 →